Parkinson named CEO of CereMedix

Steve Parkinson was appointed chairman and CEO of proteomics company CereMedix (Boston, Mass.). Prior, Parkinson was president and CEO of TranXenoGen (LSE:TXN). He takes over responsibilities from fou...